Bluejay Diagnostics, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 2.54 million compared to USD 2.01 million a year ago. Basic loss per share from continuing operations was USD 2.4 compared to USD 2 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6513 USD | +8.55% | +22.91% | -46.61% |
05-31 | Bluejay Diagnostics, Inc. announced a financing transaction | CI |
05-15 | Bluejay Diagnostics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-46.61% | 1.75M | |
-41.39% | 8.02B | |
+3.25% | 3.43B | |
-0.37% | 2.27B | |
-19.19% | 2.03B | |
-22.57% | 1.63B | |
+32.82% | 1.16B | |
-8.30% | 703M | |
+14.12% | 714M | |
-31.22% | 500M |
- Stock Market
- Equities
- BJDX Stock
- News Bluejay Diagnostics, Inc.
- Bluejay Diagnostics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023